- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02591069
Vagal Nerve Stimulation in Coma Patients (SNV)
November 21, 2019 updated by: Hospices Civils de Lyon
Vagus Nerve Stimulation in Patients With Chronic Consciousness Disorders
Minimally Conscious (MCS) or Vegetative State (VS) are disorders of consciousness which often occur following traumatic brain injury or ischemia.
These alterations result most of the time in patients' loss of autonomy and require long years of special care.
No efficient therapy to improve patients' consciousness has been found so far.
Investigators propose to use vagal nerve stimulation (VNS) to restore cortical activity and patients' embodied self.
The investigators' main hypothesis is that VNS will reestablish the thalamo-cortical connectivity leading to an improvement of the consciousness state.
To test this hypothesis, investigators will use behavioral measures as well as fMRI, PET scan and EEG to assess brain activity.
Patients will be evaluated before and during eight months following implantation of the stimulation device.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
4
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bron, France, 69500
- Recruiting
- Hôpital Neurologique de Lyon Pierre Wertheimer
-
Contact:
- Jacques Luauté, MD
- Phone Number: 0033 4 72 35 78 95
- Email: jacques.luaute@chu-lyon.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged between 18 and 60 years old
- Patients with history of cranial trauma, cerebrovascular accident, or other event leading to cerebral anoxia, suffering of chronic alteration of consciousness (Vegetative State, Minimally Conscious State, akinetic mutism). The diagnostic will be based on clinical scales
- Patients already having a neurophysiologic checkup (EEG)
- Patients breathing without invasive help, and who are in a stable medical state
- Patients with a history of disease of at least 6 months
- Patients without clinical evolution for several months
- Patients with social security
- Patients for whom a family member have signed a written consent
Exclusion Criteria:
- Patients with tracheotomy
- Pregnant women
- Intubated patients
- Patients with damaged vagus nerves
- Patients with pre existing neurological conditions other than the one responsible for the consciousness disorder
- Patients with medical complications
- Patients suffering of septic infection
- Patients with a significant dysphagia
- Patients with dyspnea or shortness of breath
- Patients with obstructive sleep apnea
- Patients with any conditions non authorized by the stimulating device manufacturer (Cyberonics)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: All patients will undergo the same procedure
|
All patients included in the study will undergo baseline assessment of all measures before surgery (implantation of a vagus nerve stimulation device).
A second baseline assessment will take place after surgery, before the beginning of the stimulation.
Stimulation intensity will start at 0.25mA and increase progressively by 0.25mA each week until reaching 1mA.
Then, intensity will be set at 1.5mA (recommended by manufacturer) and will stay to this level until the end of the trial.
Experimenters will keep the right to modify these parameters depending on patients' reaction to the treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change over time of clinical scores on the Coma Recovery Scale - Revised
Time Frame: First assessment one week before implantation second assessment 3 weeks after implantation, then once per week for a month starting one week after the beginning of stimulation; then once a month for 6 months.
|
The primary outcome will be the change over time of patients' clinical state.
Investigators will employ a widely used scale: Coma Recovery Scale - Revised.
Patients will be evaluated by the same trained doctor.
Results will be analyzed using a within subject design, each patients will be his own control.
Investigators predict a progressive improvement after the onset of treatment, compared to the two pre-stimulation evaluations.
|
First assessment one week before implantation second assessment 3 weeks after implantation, then once per week for a month starting one week after the beginning of stimulation; then once a month for 6 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of brain activity changes using EEG
Time Frame: First assessment one week before implantation second assessment 3 weeks after implantation, then once per week for a month starting one week after the beginning of stimulation, then once a month for 6 months.
|
EEG will allow investigators to monitor brain activity at rest as well as in response to various sensory stimuli.
Investigators will measure changes in evoked potentials, source of activity and frequency power known to be altered in coma patients.
In addition EEG will offer the opportunity to record brain activity while the stimulating device is on.
|
First assessment one week before implantation second assessment 3 weeks after implantation, then once per week for a month starting one week after the beginning of stimulation, then once a month for 6 months.
|
MRI (anisotropy and fibers density) evaluation of anatomo-connectivity changes
Time Frame: First assessment one week before implantation second assessment 3 weeks after implantation and then one, three and six months after the onset of stimulation.
|
Investigators will use Diffusion Tensor Imaging (DTI) before and after VNS to evaluate anisotropy and anatomical connectivity between brain stem, thalamus and various cortical areas, especially regarding the thalamo-cortical loops.
During the MRI exams the stimulation device will be turned off for safety reasons.
|
First assessment one week before implantation second assessment 3 weeks after implantation and then one, three and six months after the onset of stimulation.
|
fMRI evaluation of bold signal resting state activity and functional connectivity changes
Time Frame: Firsts First assessment one week before implantation second assessment 3 weeks after implantation,, and then one, three and six months after the onset of stimulation.
|
WInvestigators will perform resting state analysis of bold signal and functional connectivity to quantify reactivation of brain region after VNS and inter region communication, especially regarding the thalamo-cortical loops.
During the fMRI exams the stimulation device will be turned off for safety reasons.
|
Firsts First assessment one week before implantation second assessment 3 weeks after implantation,, and then one, three and six months after the onset of stimulation.
|
PET scan evaluation of brain metabolism (Glucose consumption) changes
Time Frame: One baseline assessment one week before stimulation and a second one after 3 months of stimulation.
|
Investigators will use the radioligand Fluorodesoxyglucose [18F-FDG] to assess brain consumption of glucose.
This measure is complementary to the one provided by fMRI and has already been used in coma patients.
Moreover, thanks to a hybrid MRI/PET scanner, investigators will perform the two exams simultaneously to correlate these two measures in real time.
|
One baseline assessment one week before stimulation and a second one after 3 months of stimulation.
|
Monitoring heart rate variability
Time Frame: First assessment one week before implantation second assessment 3 weeks after implantation, then once per week for a month starting one week after the beginning of stimulation, then once a month for 6 months.
|
Investigators hypothesize that VNS will modulate several physiological parameters, among those Heart Rate Variability, a marker of the balance between sympathetic and parasympathetic activity.
Investigators will measure changes of high frequencies / low frequencies ratio.
|
First assessment one week before implantation second assessment 3 weeks after implantation, then once per week for a month starting one week after the beginning of stimulation, then once a month for 6 months.
|
: Monitoring changes of serum free serotonin concentration
Time Frame: First assessment one week before implantation second assessment 3 weeks after implantation, then once per week for a month starting one week after the beginning of stimulation, then once a month for 6 months.
|
Vagus nerve is known to stimulate raphe nuclei, the region of serotonin synthesis.
Investigators hypothesize that VNS will increase serum free serotonin concentration.
Investigators will measure it using high performance liquid chromatography, and report the changes of values of serotonin concentration.
|
First assessment one week before implantation second assessment 3 weeks after implantation, then once per week for a month starting one week after the beginning of stimulation, then once a month for 6 months.
|
Monitoring changes of thermal reaction to emotional stimuli
Time Frame: First assessment one week before implantation second assessment 3 weeks after implantation, then once per week for a month starting one week after the beginning of stimulation, then once a month for 6 months.
|
Investigators will use regulation of facial temperature as an index of consciousness.
When humans react to emotions, the temperature of their face changes.
This regulation is dependent on consciousness state, and therefore should vary across time in this protocol.
Investigators will measure changes in temperature (°Celsius) of patients' face throughout the task.
|
First assessment one week before implantation second assessment 3 weeks after implantation, then once per week for a month starting one week after the beginning of stimulation, then once a month for 6 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jacques Luauté, Pr, Hospices Civils de LYON
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2015
Primary Completion (Actual)
January 1, 2016
Study Completion (Anticipated)
January 1, 2021
Study Registration Dates
First Submitted
October 6, 2015
First Submitted That Met QC Criteria
October 28, 2015
First Posted (Estimate)
October 29, 2015
Study Record Updates
Last Update Posted (Actual)
November 25, 2019
Last Update Submitted That Met QC Criteria
November 21, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Neurocognitive Disorders
- Brain Damage, Chronic
- Neurodevelopmental Disorders
- Unconsciousness
- Language Disorders
- Communication Disorders
- Speech Disorders
- Consciousness Disorders
- Persistent Vegetative State
- Mutism
- Akinetic Mutism
Other Study ID Numbers
- 2013-833
- 2014-A00125-42 (Other Identifier: ID-RCB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Minimally Conscious State
-
Hangzhou Normal UniversityCompletedPatients in Minimally Conscious State
-
University Hospital, Clermont-FerrandMedtronic; Fondation de l'AvenirCompletedChronic and Severe Post-coma Disorders of Consciousness (Permanent Vegetative State, Minimally Conscious State)France
-
Hangzhou Normal UniversityCompletedPatients in Minimally Conscious State After a Severe Brain Injury
-
Casa Colina Hospital and Centers for HealthcareUCLA Department of Psychology; Tiny Blue Dot INC.CompletedTraumatic Brain Injury | Disorder of Consciousness | CVA (Cerebrovascular Accident) | Minimally Conscious State | Vegetative State | Thalamic Infarction | Coma; Prolonged | Minimally Conscious State Plus | Minimally Conscious State Minus | Anoxia, BrainUnited States
-
University of LiegeCompletedPatients in Minimally Conscious State After a Severe Brain Injury (e.g., Anoxia, Traumatic Brain Injury, Stroke)Belgium
-
Hangzhou Normal UniversityCompletedMinimally Conscious State | Vegetative State
-
IRCCS San Camillo, Venezia, ItalyCompletedMinimally Conscious State | Vegetative StateItaly
-
Hangzhou Normal UniversityCompleted
-
Jing WangCompletedMinimally Conscious State | Vegetative StateChina
-
Hangzhou Normal UniversityCompletedMinimally Conscious State | Vegetative StateChina
Clinical Trials on stimulation device
-
Neurolief Ltd.Terminated
-
Neurolief Ltd.Completed
-
University of British ColumbiaUnited States Department of DefenseNot yet recruitingSpinal Cord Injuries | Autonomic DysfunctionCanada
-
EMKinetics, IncTerminated
-
Seoul National University HospitalRecruitingDysphagiaKorea, Republic of
-
Seoul National University HospitalCompleted
-
RML Specialty HospitalCompletedMuscle WeaknessUnited States
-
Northwestern UniversityEvergreen InvitationalCompletedObstetric Anal Sphincter Injury | Vaginal Electrical StimulationUnited States
-
University of ManchesterManchester University NHS Foundation Trust; Firstkind LtdUnknown
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruiting